Thus, the limit of detection for EGFR mutations in cfDNA from NSCLC patients were 0.05% in all three technologies, NGS, F-PHFA and ddPCR, which is comparable to previous findings [16]. Here, EGFR is linked to non-small cell lung carcinoma.